Navigation Links
Pharmacyclics Reports Third Quarter 2008 Financial Results
Date:4/24/2008

a-bearing animal

models resulted in inhibition of tumor growth and significant

activity in animal models of arthritis.

-- Plan to initiate Phase 1/2 trial evaluating HDAC inhibitor, PCI-24781,

given orally in hematologic malignancies in second quarter of 2008.

-- Plan to file investigational new drug (IND) application for the

company's Factor VIIa inhibitor in the second half of 2008.

-- Plan to file IND application for the company's small molecule Btk

inhibitor in the second half of 2008.

Conference Call and Webcast Details

The Company will hold a conference call today at 4:30 p.m. EDT to discuss third quarter 2008 financial results and achievements. To participate in the conference call, please dial 800-497-0451 for domestic callers and 706-758-3306 for international callers and reference conference passcode, 43624853. To access the live audio broadcast or the subsequent archived recording, log on to http://ir.pharmacyclics.com. The archived version of the webcast will be available on the company's website for one month.

About Pharmacyclics

Pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule drug development expertise to build a pipeline in oncology and other diseases based on a wide range of targets, pathways and mechanisms. More information about the company, its technology, and products can be found at http://www.pharmacyclics.com. Pharmacyclics(R), and the "pentadentate" logo(R) are registered trademarks of Pharmacyclics, Inc.

NOTE: Other than statements of historical fact, the statements made in this press release about our expected cash used in operations over the next four quarters, the initiation of and enrollment and future plans f
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
2. Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
3. Pharmacyclics Announces Conference Call to Discuss Third Quarter 2008 Financial Results
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... NJ Top Dentist, Dr. Susan Goldfarb, had ... a CPR Course for members of the Bergen County Dental Society. She does ... latest CPR recommendations for Healthcare Providers. Life Support from Hackensack Hospital provided the ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... imaging. The company provides high quality record management services for patient records. Medical ... is normally required by physicians and clinics. , With the increase in ...
(Date:6/30/2015)... ... June 30, 2015 , ... Eldermark Software ... Notify™, for the senior care sector. As an innovator of senior care ... to become more efficient and offer residents better care. , This next-generation interactive ...
(Date:6/30/2015)... ... June 30, 2015 , ... Harbor Village Detox ... addiction care in Florida on June 12th. Holly Vasquez-Cortella was recently quoted as ... a website dedicated to reporting on trending addiction news and treatment innovations. The article ...
(Date:6/30/2015)... ... June 30, 2015 , ... Nuretix Research, creators ... Knockout Zone Miami (KO Zone), a state-of-the-art training facility owned by ... Diego de Vera. The partnership will provide KO Zone clients and athletes with ...
Breaking Medicine News(10 mins):Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 2Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 3Health News:Micro Com Systems Ltd Now Specializes in Medical Imaging 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 3Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 3Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 2Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 3
... is available in French . Montreal -- ... times more likely to develop respiratory or gastrointestinal infections in the ... a Centre d,Hbergement de Soins de Longue Dure (CHLSD). These are ... Canadian Medical Association Journal today. "There certainly seems to ...
... both breast cancers and leukemias, according to two reports published ... Medicine ( http://www.jem.org ). The single protein is ... in the cell. , A team led by Ute Moll ... HSP90 activity rendered normally protected proteins vulnerable to attack and ...
... mothers have garnered accolades for rescuing skinned knees on ... lullabies. Now they,re gaining merit for their offspring,s physical ... published in the journal Psychological Science , Brandeis ... the University of British Columbia and the University of ...
... , MONDAY, Jan. 23 (HealthDay News) -- ... increased risk for respiratory or gastrointestinal infections if they ... or spring, according to a new study. Canadian ... care facilities in Toronto, Ontario, and Montreal and Riviere-du-Loup, ...
... International Conference on Cell Therapy for Cardiovascular Disease ... a comprehensive program dedicated to the evolving field ... of cardiac and vascular disease, as well as ... year,s conference will focus on preclinical and clinical ...
... You could call it paying it forward. A trip to ... what if the information documented as a result of your ... few provinces away? Terry Klassen and his research team ... Canada (PERC) have done just that and the impact of ...
Cached Medicine News:Health News:Emergency room visits risky for elderly residents from long-term care facilities 2Health News:Nurturing mothers rear physically healthier adults 2Health News:Nurturing mothers rear physically healthier adults 3Health News:Certain Seniors at Risk for Infection After ER Visit: Study 2Health News:Global conference on stem cell therapy for heart disease to be held Jan. 25-27 in NYC 2Health News:Global conference on stem cell therapy for heart disease to be held Jan. 25-27 in NYC 3Health News:Pediatric emergency research team hit the mark 2
(Date:6/30/2015)... Pulse Light Clinic in ... sufferers as part of their ongoing research into the condition. ... for their Rosacea. The survey participants were aged between 20 ... 53% women. The results revealed some rather surprising ... or attempt to visit their GP for Rosacea treatment. ...
(Date:6/30/2015)... Calif. , June 30, 2015  Ardelyx, Inc. ... on cardio-renal, gastrointestinal and metabolic diseases, today announced that ... July 14, 2015, from 8:00 a.m.- 1:00 pm EDT ... The Ardelyx senior management team will present ... lead compound, tenapanor, which has completed Phase 2b clinical ...
(Date:6/30/2015)... SEATTLE , BERKELEY, Kalifornien, und KOPENHAGEN, ... CMC Biologics, Inc. , ein Weltmarktführer der ... und anderen therapeutischen Proteinen, gab heute bekannt, ... Expansionsstrategie der Produktionskapazität den Ausbau der nordamerikanischen ... , mit der Ergänzung  einer Einweg-Anlage Bioreactor ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 3
... sufferers that chronic Lyme doesn,t exist; no viable alternative explanations given ... BETHESDA, Md. , ... Connecticut Attorney General, and nine months of review, the Infectious Diseases ... disease treatment guidelines with a status quo decision critics call "highly suspect." ...
... JAMESBURG, N.J. , April 28 Phytomedics Inc., a clinical ... solely derived from plant sources, today announced that Dr. Laurie Smaldone ... at the BIO 2010 International Convention on Thursday, May 6th , ... , , ...
Cached Medicine Technology:Judge, Jury = Status Quo: Astonishment as Medical Panel Rubber Stamps its Own Controversial Guidelines 2Judge, Jury = Status Quo: Astonishment as Medical Panel Rubber Stamps its Own Controversial Guidelines 3Phytomedics Inc. To Present at BIO 2010 International Convention 2
... factor I (IGF-I or somatomedin C) is a ... It acts as a potent mitogen of cellular ... cell-surface receptors. In the circulation, IGF-I is bound ... the actions of IGF-I by modulating the interaction ...
... somatomedin C) is a 7.6 kDa peptide produced ... potent mitogen of cellular proliferation, exerting its actions ... circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), ... by modulating the interaction of IGF-I with the ...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
Image Diagnostics' Aspect100U is specifically designed for ease of use and high quality image outcome during urological procedures. Aspect tables benefit from a trim, lightweight design, ensuring a s...
Medicine Products: